Allogene Therapeutics, Inc. (ALLO) Tops Q4 EPS by 4c

Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• JPMorgan Resumes Drax Group Plc. (DRX:LN) (DRXGY) at Overweight
• Walmart (WMT) PT Lowered to $130 at Goldman Sachs